Tag: Drug Approvals
FDA Approves Radicava for Amyotrophic Lateral Sclerosis
Radicava, given intravenously, slows physical decline in patients with ALS
Enzyme Replacement Drug OK’d for Form of Batten Disease
Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten
FDA Approves Kinase Inhibitor for Treatment of AML
Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults
Regorafenib Approved for Hepatocellular Carcinoma
It is the first approved treatment for HCC in almost a decade
FDA OKs Vagus Nerve Stimulator to Treat Cluster Headaches
Hand-held, noninvasive device provides new option
FDA Approves First Drug for Treatment of Tardive Dyskinesia
Ingrezza (valbenazine) capsules approved for treatment of adults with tardive dyskinesia
FDA Approves Dupixent to Treat Eczema
Active ingredient binds to protein (interleukin-4 receptor alpha subunit) that causes inflammation
FDA Approves Ocrevus to Treat Severe Form of Multiple Sclerosis
First drug sanctioned in United States for primary progressive multiple sclerosis
FDA Approves Zejula for Certain Female Cancers
PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum
FDA Approves Bavencio for Merkel Cell Carcinoma
Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States
